Individuals who take Ozempic and similar weight loss drugs prior to undergoing medical procedures involving sedation face a higher risk of lung infection, according to a recent study.
The peer-reviewed study, published in the Cureus journal on Aug. 6, investigated the incidences of aspiration and pneumonia among patients taking GLP-1 drugs including Ozempic and Wegovy. Aspiration happens when food enters the lungs instead of being swallowed.
